Redhill BiopharmaSTU:2RH 18 EV-to-FCF is -4.84 as of Jul. 02, 2026. GuruFocus rates STU:2RH with a GF Score™ of 18/100. The stock has 6 warning signs investors should review. Among 561 Drug Manufacturers companies, Redhill Biopharma ranks worse than 178252.94% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Redhill Biopharma's Enterprise Value is €40.20 Mil.
Redhill Biopharma's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €-8.31 Mil. Therefore, Redhill Biopharma's EV-to-FCF for today is -4.84.
The historical rank and industry rank for Redhill Biopharma's EV-to-FCF or its related term are showing as below:
STU:2RH'
s EV-to-FCF Range Over the Past 10 Years
Min: -6.66 Med: -3.28 Max: 0.21
Current: -0.15
During the past 13 years, the highest EV-to-FCF of Redhill Biopharma was 0.21. The lowest was -6.66. And the median was -3.28.
STU:2RH's EV-to-FCF is ranked worse than 100% of 561
companies
in the Drug Manufacturers industry
Industry Median: 20.16
vs STU:2RH: -0.15
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Redhill Biopharma's PE Ratio (TTM) for today is calculated as:
Redhill Biopharma's share price for today is €8.2375.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Redhill Biopharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.621.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Redhill Biopharma EV-to-FCF Related Terms
Redhill Biopharma EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Redhill Biopharma's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Redhill Biopharma's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Redhill Biopharma EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Redhill Biopharma's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Redhill Biopharma's EV-to-FCF falls into.
Redhill Biopharma's current Enterprise Value is €40.20 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Redhill Biopharma's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €-8.31 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Redhill Biopharma (STU:2RH) has a EV-to-FCF of -4.84 as of Jul. 02, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Redhill Biopharma and its competitors. According to the industry distribution chart, Redhill Biopharma ranks #999999 out of 561 companies in the Drug Manufacturers industry.
Is Redhill Biopharma's EV-to-FCF too high?
Redhill Biopharma's current EV-to-FCF is -4.84. Based on the distribution chart, Redhill Biopharma ranks #999999 out of 561 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Redhill Biopharma has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Redhill Biopharma's EV-to-FCF compare to SBFM and PRFX?
According to the Drug Manufacturers industry distribution chart, Redhill Biopharma ranks #999999 out of 561 companies for EV-to-FCF. This places Redhill Biopharma in the lower half of its industry. The industry median EV-to-FCF is 20.16. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.16, based on 561 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Redhill Biopharma and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Redhill Biopharma's current EV-to-FCF is -4.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redhill Biopharma stock overvalued right now?
Redhill Biopharma (STU:2RH) has a current EV-to-FCF of -4.84. The current EV-to-FCF is -4.84. Redhill Biopharma's overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Redhill Biopharma (STU:2RH), the current EV-to-FCF is -4.84 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.
18GF Score
Get the complete analysis for STU:2RH
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:2RH has been successfully added to your 
